These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25605650)

  • 41. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
    Lin MT; Chang CH; Sun LC; Liu HM; Chang HW; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
    J Formos Med Assoc; 2016 May; 115(5):350-5. PubMed ID: 25910931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):501.e1-11; quiz 511-2. PubMed ID: 24034379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble forms of P-, E- and L-selectin in children with Kawasaki disease.
    Furui J
    Kurume Med J; 2001; 48(2):135-43. PubMed ID: 11501494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.
    Doi M; Takeda T; Sakurai Y; Kato J; Hayashi T; Fukuda K; Takase T; Shima M
    J Investig Allergol Clin Immunol; 2010; 20(5):413-8. PubMed ID: 20945608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in helper lymphocyte chemokine receptor expression and elevation of IP-10 during acute respiratory syncytial virus infection in infants.
    Roe MF; Bloxham DM; Cowburn AS; O'Donnell DR
    Pediatr Allergy Immunol; 2011 Mar; 22(2):229-34. PubMed ID: 20561238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations.
    Kubota M; Usami I; Yamakawa M; Tomita Y; Haruta T
    J Paediatr Child Health; 2008 Jun; 44(6):359-62. PubMed ID: 18476929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.
    Hamada H; Suzuki H; Abe J; Suzuki Y; Suenaga T; Takeuchi T; Yoshikawa N; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Honda T; Onouchi Y; Terai M; Hata A
    Cytokine; 2012 Dec; 60(3):681-5. PubMed ID: 22944461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased serum interleukin-10 level in Kawasaki disease.
    Kim DS; Lee HK; Noh GW; Lee SI; Lee KY
    Yonsei Med J; 1996 Apr; 37(2):125-30. PubMed ID: 8711935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
    Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring of the serum proteome in Kawasaki disease patients before and after immunoglobulin therapy.
    Zhang L; Jia HL; Huang WM; Liu CW; Hua L; Liu TC; Mao LJ; Xu YF; Li W; Xia SL; Gan YY; Deng L; Zhang G
    Biochem Biophys Res Commun; 2014 Apr; 447(1):19-25. PubMed ID: 24690176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An elevated value of high mobility group box 1 is a potential marker for poor response to high-dose of intravenous immunoglobulin treatment in patients with Kawasaki syndrome.
    Eguchi T; Nomura Y; Hashiguchi T; Masuda K; Arata M; Hazeki D; Ueno K; Nishi J; Kawano Y; Maruyama I
    Pediatr Infect Dis J; 2009 Apr; 28(4):339-41. PubMed ID: 19238112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Varying clinical features of Turkish Kawasaki disease patients.
    Gülhan B; Kesici S; Beken S; Cilsal E; Kale G; Alehan D; Kara A; Ozen S
    Turk J Pediatr; 2012; 54(1):1-6. PubMed ID: 22397034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital.
    Kuo CC; Lee YS; Lin MR; Hsia SH; Chen CJ; Chiu CH; Hwang MS; Huang YC
    J Microbiol Immunol Infect; 2018 Apr; 51(2):184-190. PubMed ID: 27591913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating adiponectin levels in Kawasaki disease.
    Takeshita S; Takabayashi H; Yoshida N
    Acta Paediatr; 2006 Oct; 95(10):1312-4. PubMed ID: 16982510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease.
    Nakashima Y; Nanishi E; Yamamura K; Uike K; Terashi E; Hirata Y; Nagata H; Morihana E; Tanaka T; Honjo S; Takada H; Ohga S
    Cytokine; 2019 Feb; 114():26-31. PubMed ID: 30583086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The CXCL10-CXCR3 axis plays an important role in Kawasaki disease.
    Hosaka S; Imagawa K; Yano Y; Lin L; Shiono J; Takahashi-Igari M; Hara H; Hayashi D; Imai H; Morita A; Fukushima H; Takada H
    Clin Exp Immunol; 2024 Mar; 216(1):104-111. PubMed ID: 37952216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.
    Galeotti C; Bayry J; Kone-Paut I; Kaveri SV
    Autoimmun Rev; 2010 Apr; 9(6):441-8. PubMed ID: 20004744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Elevated plasma concentration of IP-10 in patients with type 2 diabetes mellitus].
    Xu H; Nakayama K; Ogawa S; Sugiura A; Kato T; Sato T; Sato H; Ito S
    Nihon Jinzo Gakkai Shi; 2005; 47(5):524-30. PubMed ID: 16130407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.